Dapagliflozin vs Tofacitinib

Dapagliflozin vs Tofacitinib: Overview

This comparison examines the pharmacological differences between Dapagliflozin and Tofacitinib.

Mechanism of Action

Dapagliflozin: Selective SGLT2 inhibitor reducing renal glucose and sodium reabsorption.

Tofacitinib: Pan-JAK inhibitor with preference for JAK1 and JAK3 blocking pro-inflammatory cytokine signaling.

Pharmacokinetics

Half-life: Dapagliflozin — 12.9 hours; Tofacitinib — 3.2 hours.

Chemical Properties

Molecular Formula: Dapagliflozin — C21H25ClO6; Tofacitinib — C16H20N6O.

Molecular Weight: Dapagliflozin — 408.8730 g/mol; Tofacitinib — 312.3700 g/mol.

Type: Dapagliflozin — Small molecule; Tofacitinib — Small molecule.